IRCT20220412054515N1招募中3 期
Comparison of enoxaparin effects with prophylactic or therapeutic dosage on overall survival in severe COVID-19 patients
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •COVID-19 infection diagnosed by PCR
- •Hospitalization requirement
- •Having at least two signs of severe COVID-19 infection: (1) respiratory rate>30 (2) Spo2<93% (3) Pao2/Fio2<300 (4) progression in CT scan imaging>50% in 48 hours
排除标准
- •History of CVA in last month
- •History of major surgery in last two weeks
- •History of heparin induced thrombocytopenia
- •Other definitive indications for therapeutic enoxaparin treatment
- •Any contraindication for enoxaparin treatment
研究者
相似试验
招募中
3 期
The effectiveness of enoxaparin in preventing deep vein thrombosisDeep vein thrombosis.Phlebitis and thrombophlebitis of other deep vessels of lower extremitiesI80.2IRCT20210602051484N1Zanjan University of Medical Sciences200
已完成
不适用
Evaluation of prophylactic enoxaparin sodium in the prevention of venous thromboembolism after gynecological laparoscopic surgeryJPRN-UMIN000008273agasaki University100
招募中
3 期
Enoxaparin in Treatment of Vascular Intra-Uterine Growth RetardatioIntra-uterine growth retardation.IRCT20180819040830N4Tehran University of Medical Sciences126
招募中
不适用
Comparison of the effect of enoxaparin and aspirin on the prevention of deep vein thrombosis after spinal surgeryDeep venous thrombosis.Phlebitis and thrombophlebitis of lower extremities, unspecifiedI80.3IRCT20221014056171N1Mashhad University of Medical Sciences100
已完成
3 期
Safety and usefulness of Enoxaparin versus unfractionated heparin in patients with ST elevation myocardial infarctioIschaemic heart diseases.Acute myocardial infarctionIRCT138711271695N1Tehran University of Medical Sciences and Health Services150